| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |